This changes everything
Taking things further with how I attempt to prevent recurrence of my brain tumour.
New developments bring promise for a better future
A new product has recently entered the market, aiming to transform the way we effectively monitor therapeutic ketogenic approaches in managing conditions such as cancer, epilepsy, and diabetes. Continuous glucose monitors have been available for quite some time, but it's only now that we have a continuous ketone monitor.
I knew that several companies, including the market leader Abbott, intended to release a product with this capability, but the timeline for its launch remained uncertain.
The SiBio KS1 Continuous Ketone Monitoring Sensor is a continuous 24 hour blood ketone monitor that allows the user to visualise and optimise an individual therapeutic ketogenic approach. The device offers a level of precision and personalisation that would be difficult to achieve with other methods.
Keep reading with a 7-day free trial
Subscribe to Andrew’s Substack to keep reading this post and get 7 days of free access to the full post archives.